+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
SAMPRE SAMPRE

Sampre Nutritions Share Price

₹4.16 -0.12 (-2.8%)
New 52W Low in past week

13 Nov, 2026 10:31 AM (IST)

Sampre Nutritions live price: ₹4.16. It opened at ₹4 vs previous close ₹4; intraday high/low: ₹4/₹4. The 50 & 200 DMA stand at ₹5.30/₹10.50.

Sampre Nutritions Performance

  • Today's Low
  • ₹4
  • Today's High
  • ₹4
  • 52 Week Low
  • ₹4
  • 52 Week High
  • ₹39
  • Open Price₹4
  • Previous Close₹4
  • Volume75,765
  • 50 DMA₹5.30
  • 100 DMA₹7.00
  • 200 DMA₹10.50

Sampre Nutritions Chart

Investment Returns

  • Over 1 Month -18.27%
  • Over 3 Month -32.14%
  • Over 6 Month -73.11%
  • Over 1 Year -87.84%

Smart Investing Starts Here Start SIP with Sampre Nutritions for Steady Growth!

Invest Now

Sampre Nutritions Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 12.7
  • PEG Ratio
  • 0.1
  • Market Cap Cr
  • 37
  • P/B Ratio
  • 0.4
  • Average True Range
  • 0.4
  • EPS
  • 0.3
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.4
  • RSI
  • 39.54
  • MFI
  • 20.52

Latest Stock News Updates

Sampre Nutritions Ltd - 530617 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Intimation of unaudited standalone and consolidation results for the second quarter ended 30 September 2026 in the newspaper.

Sampre Nutritions Ltd - 530617 - Board Meeting Outcome for Unaudited Financial Results For The Second Quarter Ended 30 September 2026

In compliance with Regulation 33 of the SEBI (LODR) Regulations, 2015, the unaudited standalone and consolidated financial results along with the limited review report, is attached for the second quarter ended 30 September 2026 for the financial year 2026-27.

Sampre Nutritions Ltd - 530617 - Board Meeting Intimation for Approving Q2 Results For The Quarter Ended 30 September 2026

Sampre Nutritions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2026 ,inter alia, to consider and approve unaudited standalone and consolidated financial results of the Company for the second quarter ended 30 September 2026 for the financial year 2026-27.

Sampre Nutritions Financials

Sampre Nutritions Technicals

EMA & SMA

Current Price
₹4.16
-0.12 (-2.8%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹4.60
  • 50 Day
  • ₹5.30
  • 100 Day
  • ₹7.00
  • 200 Day
  • ₹10.50

Resistance and Support

4.22 Pivot Speed
  • R3 4.60
  • R2 4.50
  • R1 4.40
  • S1 4.10
  • S2 4.00
  • S3 3.90

Sampre Nutritions Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-11-06 Quarterly Results
2026-08-05 Quarterly Results & A.G.M.
2026-05-29 Audited Results
2026-02-13 Quarterly Results
2025-11-05 Quarterly Results & Others Inter alia, to consider 1. Preferential issue of shares. 2. Approve to issue equity shares by way of sweat equity; and conversion of loan into equity shares.
Date Purpose Remarks
2025-11-14 Split Stock split from Rs. 10/- to Rs. 5/-.
Date Purpose Remarks
2025-11-14 Bonus Bonus issue of equity shares in the ratio of 1:1 of Rs. 5/-.

Sampre Nutritions Shareholding Pattern

85.96%
14.04%
0%

About Sampre Nutritions

Sampre Nutritions is an Indian public company. Specializing in the manufacturing of sugar-boiled candies, toffees, eclairs, center-filled items, and healthcare/powder confectionery products. View More
  • NSE Symbol
  • SAMPRE
  • BSE Symbol
  • 530617
  • ISIN
  • INE375C01022

Similar Stocks to Sampre Nutritions

Sampre Nutritions FAQs

Sampre Nutritions share price is ₹4 As on 13 November, 2026 | 10:17

The Market Cap of Sampre Nutritions is ₹37.1 Cr As on 13 November, 2026 | 10:17

The P/E ratio of Sampre Nutritions is 12.7 As on 13 November, 2026 | 10:17

The PB ratio of Sampre Nutritions is 0.4 As on 13 November, 2026 | 10:17

The 52 week High & Low of Sampre Nutritions is ₹39/₹4 respectively As on 13 November, 2026 | 10:17

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23